HITLAB Team • November 21, 2023
NEW YORK, Nov 21, 2023 — Metfora, a promising AI-based diagnostic solutions company, is embarking on an exciting collaboration with HITLAB (Healthcare Innovation and Technology Lab) to innovate and transform chronic disease diagnosis.
In this strategic collaboration, HITLAB, is teaming up with Metfora to conduct a comprehensive market evaluation study. This study will assess the economic impact and usability of Metfora’s cutting-edge diagnostic solutions. HITLAB’s extensive experience in healthcare innovation and its vast network of experts will play a pivotal role in this venture.
Metfora’s AI-based blood test is poised to revolutionize healthcare by enabling early disease detection and intervention. By analyzing circulating metabolites and extracting disease-specific “metabolic fingerprints” using AI (Artificial Intelligence), this diagnostic tool promises to improve patient outcomes and reduce healthcare costs.
The project’s scope includes a market evaluation study, in which HITLAB and Metfora will collaborate to determine the economic impact of the diagnostic solution. In addition, HITLAB will support Metfora in preparing for a clinical validation study, a crucial evidence generation step in bringing this technology to the forefront of healthcare.
The AI-based diagnostic solution not only has immediate applications in healthcare, but also holds the potential for broader uses across various sectors. HITLAB’s vast network and expertise will be leveraged to identify licensing opportunities, negotiate with potential partners, and create valuable contacts across the healthcare industry.
Martin Fuchs, Founder and CEO of Metfora, expressed his enthusiasm for the collaboration, saying, “We are delighted to launch this promising collaboration with HITLAB and see the project providing great value to our company.”
Stan Kachnowski, PhD MPA, HITLAB Chair, added, “Excited to embark on this transformative journey with Metfora. Our joint efforts aim to redefine chronic disease diagnosis, and the potential for broader applications is truly groundbreaking. Looking forward to making a lasting impact together.”
This partnership marks the beginning of an exciting chapter for Metfora and HITLAB as they embark on their mission to redefine healthcare technology for chronic disease diagnosis.
About Metfora
Metfora is a pioneering healthcare technology company on a mission to reshape healthcare through cutting-edge AI solutions. Their AI-powered blood test is set to impact healthcare by enabling early disease detection and intervention, ultimately improving patient outcomes, and reducing healthcare costs.
About HITLAB
HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world. Their mission is to harness technology and health to improve healthcare quality globally, employing rigorous research and evidence-based methods to identify the best digital health solutions for partners.
Learn more about
